Discontinued — last reported Q3 '25
Non-Current Assets
Intangibles (Net)
West Pharmaceutical Services Intangibles (Net) decreased by 9.1% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.0%, from $10.00M to $7.00M. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -24.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ3 2025
How to read this metric
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
Detailed definition
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Peer comparison
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
Metric ID:
intangible_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.80M | $26.10M | $23.00M | $21.80M | $20.00M | $18.10M | $18.40M | $17.80M | $16.80M | $15.70M | $15.10M | $13.90M | $12.90M | $12.30M | $10.80M | $10.00M | $9.70M | $8.90M | $7.70M | $7.00M |
| QoQ Change | — | -6.1% | -11.9% | -5.2% | -8.3% | -9.5% | +1.7% | -3.3% | -5.6% | -6.5% | -3.8% | -7.9% | -7.2% | -4.7% | -12.2% | -7.4% | -3.0% | -8.2% | -13.5% | -9.1% |
| YoY Change | — | — | — | — | -28.1% | -30.7% | -20.0% | -18.3% | -16.0% | -13.3% | -17.9% | -21.9% | -23.2% | -21.7% | -28.5% | -28.1% | -24.8% | -27.6% | -28.7% | -30.0% |
Range$7.00M – $27.80M
CAGR-25.2%
Avg YoY Growth-23.7%
Median YoY Growth-24.0%
Current Streak13 quarters decline
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's intangibles (net)?
- West Pharmaceutical Services (WST) reported intangibles (net) of $7.00M in Q1 2026.
- How has West Pharmaceutical Services's intangibles (net) changed year-over-year?
- West Pharmaceutical Services's intangibles (net) decreased by 30.0% year-over-year, from $10.00M to $7.00M.
- What is the long-term trend for West Pharmaceutical Services's intangibles (net)?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's intangibles (net) has grown at a -24.1% compound annual growth rate (CAGR), from $30.50M to $7.70M.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and brands after accounting for amortization.